Chris French
Technik-/Wissenschafts-/F&E-Leiter bei CHECKMATE PHARMACEUTICALS, INC.
Profil
Chris French is currently the Vice President-Scientific Affairs at Checkmate Pharmaceuticals, Inc. She holds a Master's in Business Administration from St. Thomas University (Florida) and an undergraduate degree from the University of Mankato.
Aktive Positionen von Chris French
| Unternehmen | Position | Beginn |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2016 |
Ausbildung von Chris French
| University of Mankato | Undergraduate Degree |
| St. Thomas University (Florida) | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
